Trial Profile
Neurodevelopmental Outcome After Standard Dose Sevoflurane Versus Low-dose Sevoflurane/Dexmedetomidine/Remifentanil Anaesthesia in Young Children- The TREX Trial
Status:
Active, no longer recruiting
Phase of Trial:
Phase III
Latest Information Update: 03 May 2023
Price :
$35
*
At a glance
- Drugs Dexmedetomidine (Primary) ; Remifentanil (Primary) ; Sevoflurane (Primary)
- Indications Anaesthesia
- Focus Therapeutic Use
- Acronyms The TREX Trial
- 27 Apr 2023 Status changed from recruiting to active, no longer recruiting.
- 07 Feb 2023 Planned End Date changed from 1 Dec 2025 to 1 Jun 2026.
- 07 Feb 2023 Planned primary completion date changed from 1 Dec 2022 to 1 Jun 2023.